FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965619170> ?p ?o ?g. }

• W1965619170 endingPage "170" @default.
• W1965619170 startingPage "166" @default.
• W1965619170 abstract "<h2>Abstract</h2><h3>BACKGROUND</h3> Endothelial monocyte-activating polypeptide-II (EMAP-II) is a proinflammatory cytokine with antiangiogenic properties. Serum EMAP-II levels have not been investigated previously in non–small-cell lung cancer (NSCLC). The aim of this study was to examine the relationship between serum EMAP-II levels and clinicopathologic features, including prognosis, in patients with NSCLC. <h3>PATIENTS AND METHODS</h3> We measured serum EMAP-II levels in 30 healthy control subjects and 48 patients with untreated NSCLC by enzyme linkedimmunosorbent assay. <h3>RESULTS</h3> Patients with NSCLC had significantly higher serum EMAP-II levels than did the control group (492 pg/mL ± 1126 pg/mL vs. 266 pg/mL ± 1013 pg/mL; <i>P</i> = .015). No significant association was found between serum EMAP-II levels and various clinicopathologic features (age, smoking history, performance status, histopathology, tumor stage, lymph node stage, or distant metastasis). Median survival time was 10.13 months (range, 2-53.8 months). The high–EMAP-II (≥ 100 pg/mL) group had a shorter survival compared with the low–EMAP-II (< 100 pg/mL) group (<i>P</i> = .023), and the serum EMAP-II level was still an important predictor of survival in a multivariate analysis, along with disease stage. <h3>CONCLUSION</h3> Our results showed that serum EMAP-II levels are significantly higher in patients with NSCLC than in healthy subjects and suggest it is of potential prognostic value." @default.
• W1965619170 created "2016-06-24" @default.
• W1965619170 creator A5008048783 @default.
• W1965619170 creator A5033234505 @default.
• W1965619170 creator A5046007558 @default.
• W1965619170 creator A5053762770 @default.
• W1965619170 creator A5082504401 @default.
• W1965619170 date "2008-05-01" @default.
• W1965619170 modified "2023-10-17" @default.
• W1965619170 title "Serum Endothelial Monocyte-Activating Polypeptide–II: A Novel Biomarker in Patients with Non–Small-Cell Lung Cancer" @default.
• W1965619170 cites W1579598940 @default.
• W1965619170 cites W1605519347 @default.
• W1965619170 cites W1905416609 @default.
• W1965619170 cites W1971434769 @default.
• W1965619170 cites W1989664813 @default.
• W1965619170 cites W1993312546 @default.
• W1965619170 cites W2010397777 @default.
• W1965619170 cites W2020830322 @default.
• W1965619170 cites W2034336067 @default.
• W1965619170 cites W2045411190 @default.
• W1965619170 cites W2052182008 @default.
• W1965619170 cites W2058222082 @default.
• W1965619170 cites W2064795528 @default.
• W1965619170 cites W2067079290 @default.
• W1965619170 cites W2076668534 @default.
• W1965619170 cites W2076695875 @default.
• W1965619170 cites W2085259202 @default.
• W1965619170 cites W2087911316 @default.
• W1965619170 cites W2091300651 @default.
• W1965619170 cites W2094406892 @default.
• W1965619170 cites W2096682049 @default.
• W1965619170 cites W2101436113 @default.
• W1965619170 cites W2120499500 @default.
• W1965619170 cites W2125131472 @default.
• W1965619170 cites W2147829987 @default.
• W1965619170 cites W2153649717 @default.
• W1965619170 cites W2164008484 @default.
• W1965619170 cites W2171475230 @default.
• W1965619170 doi "https://doi.org/10.3816/clc.2008.n.025" @default.
• W1965619170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18621627" @default.
• W1965619170 hasPublicationYear "2008" @default.
• W1965619170 type Work @default.
• W1965619170 sameAs 1965619170 @default.
• W1965619170 citedByCount "7" @default.
• W1965619170 countsByYear W19656191702012 @default.
• W1965619170 countsByYear W19656191702016 @default.
• W1965619170 countsByYear W19656191702019 @default.
• W1965619170 countsByYear W19656191702020 @default.
• W1965619170 countsByYear W19656191702022 @default.
• W1965619170 crossrefType "journal-article" @default.
• W1965619170 hasAuthorship W1965619170A5008048783 @default.
• W1965619170 hasAuthorship W1965619170A5033234505 @default.
• W1965619170 hasAuthorship W1965619170A5046007558 @default.
• W1965619170 hasAuthorship W1965619170A5053762770 @default.
• W1965619170 hasAuthorship W1965619170A5082504401 @default.
• W1965619170 hasConcept C126322002 @default.
• W1965619170 hasConcept C142724271 @default.
• W1965619170 hasConcept C143998085 @default.
• W1965619170 hasConcept C146357865 @default.
• W1965619170 hasConcept C151730666 @default.
• W1965619170 hasConcept C164027704 @default.
• W1965619170 hasConcept C185592680 @default.
• W1965619170 hasConcept C2776256026 @default.
• W1965619170 hasConcept C2776914184 @default.
• W1965619170 hasConcept C2780849966 @default.
• W1965619170 hasConcept C2781197716 @default.
• W1965619170 hasConcept C55493867 @default.
• W1965619170 hasConcept C71924100 @default.
• W1965619170 hasConcept C86803240 @default.
• W1965619170 hasConcept C90924648 @default.
• W1965619170 hasConceptScore W1965619170C126322002 @default.
• W1965619170 hasConceptScore W1965619170C142724271 @default.
• W1965619170 hasConceptScore W1965619170C143998085 @default.
• W1965619170 hasConceptScore W1965619170C146357865 @default.
• W1965619170 hasConceptScore W1965619170C151730666 @default.
• W1965619170 hasConceptScore W1965619170C164027704 @default.
• W1965619170 hasConceptScore W1965619170C185592680 @default.
• W1965619170 hasConceptScore W1965619170C2776256026 @default.
• W1965619170 hasConceptScore W1965619170C2776914184 @default.
• W1965619170 hasConceptScore W1965619170C2780849966 @default.
• W1965619170 hasConceptScore W1965619170C2781197716 @default.
• W1965619170 hasConceptScore W1965619170C55493867 @default.
• W1965619170 hasConceptScore W1965619170C71924100 @default.
• W1965619170 hasConceptScore W1965619170C86803240 @default.
• W1965619170 hasConceptScore W1965619170C90924648 @default.
• W1965619170 hasIssue "3" @default.
• W1965619170 hasLocation W19656191701 @default.
• W1965619170 hasLocation W19656191702 @default.
• W1965619170 hasOpenAccess W1965619170 @default.
• W1965619170 hasPrimaryLocation W19656191701 @default.
• W1965619170 hasRelatedWork W2356105190 @default.
• W1965619170 hasRelatedWork W2372561159 @default.
• W1965619170 hasRelatedWork W2375344515 @default.
• W1965619170 hasRelatedWork W2380382254 @default.
• W1965619170 hasRelatedWork W2390152934 @default.
• W1965619170 hasRelatedWork W2793069229 @default.
• W1965619170 hasRelatedWork W2937519691 @default.
• W1965619170 hasRelatedWork W2971539372 @default.

• next